The customer stated that they received erroneous results for twenty one patient samples tested for the elecsys tsh assay (tsh), elecsys ft3 iii (ft3), the elecsys ft4 ii assay (ft4), roche diagnostics cobas elecsys anti-tpo (anti-tpo), and the elecsys anti-tshr immunoassay (anti-tshr) on a cobas 6000 e 601 module.It was asked, but it is not known if any erroneous results were reported outside of the laboratory.(b)(4).Refer to the attachment for all patient data.The erroneous values are highlighted in yellow.The samples were tested on the e601 analyzer and repeated using the delfia and siemens immulite 2000 xpi methods.No adverse events were alleged to have occurred with the patients.The e601 analyzer serial number is (b)(4).
|
The patient samples were provided for investigation.Investigations of sample 17 determined that it contained an interferent to a component of the anti-tpo assay.This limitation is covered in product labeling.An interfering factor could not be identified in samples 18 and 19.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.
|